Connect with us

Health

WHO to spend $9m to accelerate COVID-19 vaccination in 15 Nigerian states

Published

on

The World Health Organisation (WHO) is set to spend $9m to accelerate COVID vaccination in 15 Nigerian states.

The amount which is a grant from the Canadian Government to the Nigerian Federal Government will be deployed to the 15 lowest performing states in COVID-19 vaccination in Nigeria.

The donation came as the federal government declared that while it had made significant progress in its vaccination efforts, several states have primary series coverage below 70 per cent and booster doses account for just over 20 per cent of vaccinations.

The donation was announced by the Canadian High Commissioner to Nigeria, Jamie Christoff during launch of the Canada Global Initiative for Vaccine Equity, CanGIVE Grant in Abuja by the Federal Ministry of Health in collaboration with the National Primary Health Care Development Agency, NPHCDA.

Canada Global Initiative for Vaccine Equity, CanGIVE, is a two-year grant of $9,261,920 from Global Affairs Canada to the World Health Organisation, WHO to support the scale-up of COVID-19 vaccine service delivery among priority risk groups and strengthen health systems in Nigeria.

High Commissioner of Canada to Nigeria, Mr Jamie Chrisoff, said that Canada instituted CanGIVE- a alobal initiative of 317 million Canadian dollars to respond to country priorities for COVID-19.

He said it also meant to build on Canada’s long-standing global commitment to support health systems.

Chrisoff said the WHO project would be implemented in seven countries, with Nigeria receiving the highest share of 9.3 million dollars.

According to him, Nigeria is also among the first set of countries to receive COVID-19 vaccine doses from Canada in September of 2021.

WHO Country Representative, Dr Walter Mulombo said this on Wednesday in Abuja during the launch of Canada Global Initiative for Vaccine Equity (CanGIVE) grant.

Mulombo said that the grant would be implemented in the 15 lowest performing states of Benue, Kogi, Taraba, Katsina, Kebbi, Anambra, Ebonyi, Akwa Ibom, Bayelsa, Delta, Edo, Rivers, Lagos, Ogun and Ondo.

“It will help to mainstream and integrate gender-responsive, equity-based and human rights-focused interventions that promote leaving no one behind agenda in the country.

“The grant has come at the right time to help improve coverage and uptake of the vaccine among the priority populations in line with the current WHO SAGE roadmap on uses of COVID-19 vaccines,” he said.

According to him, Nigeria has made progress in the fight against COVID-19.

He said that as of July 17, 2023, 77,285, 627 persons in Nigeria have completed the primary series of COVID-19 vaccination, with, 87,838,137 persons receiving at least one dose of the vaccine.

“Also, 16,011,524 of those who have completed the primary series have received a booster dose of the vaccine,” he said.

Mulombo said that in spite of the achievement, there was still more work to be done.

“As of now 14 states are performing less than 50 per cent vaccination coverage of their target population, and we still have some vulnerable populations that are not sufficiently covered.

“Key among these subgroups are the aged (50years and above), people with co-morbidities, the health workers, people living in humanitarian and security compromised communities and the pregnant women,” he said.

Mulombo said that WHO Director General’s declaration that COVID-19 was no longer a Public Health Emergency of International Concerns (PHEIC) marked a turning point in the control of the pandemic.

He said the declaration however did not mean COVID-19 was over as a global and national health threat.

“Though considerable achievements have been made, we are still at risk of the infection as cases are still being reported in a number of countries.

“I will like to take this opportunity to caution all of us on the need to continue protecting ourselves by completing the primary series of COVID-19 vaccination.

“For those who have completed should continue with the booster dose schedule,” he said.

Mulombo assured the Ministry of Health that WHO would continue to collaborate with partners to support the government’s effort to protect vulnerable segments of the population and the structures and health systems were strengthened.

“We shall continue to provide technical support to implement one health approach to preparedness and response, and integrate COVID-19 surveillance and response activities into routine health programmes.

“Together with partners and the government we will dedicate sustained attention and resources to preparedness and resilience to counter future threats,” he said.

Mulombo appreciated the support from the Canadian government through the CanGIVE grant.

Health

Assembly passes Kano Pre-Marital Health Screening Bill

Published

on

Kano State House of Assembly has passed a bill for a law to compel intending couples to undergo HIV, hepatitis and sickle cell anaemia screening before marriage.

The passage followed deliberations in the Committee of the Whole House during plenary session,
presided over by the Speaker, Ismail Falgore on Monday in Kano.

After deliberations, the lawmakers approved the 3rd reading of the bill, read by the Deputy Clerk, Alhaji Nasiru Magaji.

Shortly after passage of the bill, the Majority Leader of the house, Lawan Hussein (NNPP-Dala), stated that “any person
intending to marry shall first submit self for medical examinations.”

He said the bill was considered and passed after the 3rd reading, following various legislative processes.

The leader further said that the bill was passed because the state had been battling with different health issues, including
HIV because people go into marriages without medical screening.

He said that the bill, if signed into law, would save many lives and curb the spread of life-threatening diseases.

“The bill will safeguard the health of citizens by institutionalising pre-marital testing to check the spread of diseases
like hepatitis, HIV and sickle cell anaemia,” he added.

Continue Reading

Health

WHO to begin vaccination against Human Papilloma Virus May 27 in Kogi

Published

on

The World Health Organisation (WHO), says it plans to commence vaccination against Human Papilloma Virus (HPV) on May 27 in Kogi.

The state’s Team Lead of WHO, Dr Muktar Toyosi, said this when he led his team on an advocacy visit to the State Council of the Nigeria Union of Journalists (NUJ) on Wednesday in Lokoja.

Toyosi said that the vaccination was meant for girl child of between the age nine and 14.

He said the ongoing sensitisation was to keep the people informed, and educate them on the vaccination of their children to protect them against cervical cancer in future.

”Kogi falls within the second phase of the programme. We are soliciting for the cooperation of the media in educating the people of the state on the HPV vaccination.

“There need for girls child across the state to take the vaccination to safeguard their future.

“Although the vaccine was initially scarce and difficult to get, the good news now is that it has been made available by the government,” Toyosi said.

Also speaking, the State Technical Assistant for WHO, Dr Ahmed Attah, said that the HPV mostly affect women, adding that the vaccination remained a preventive measure against the disease.

Attah, a former state Chairman of the Nigeria Medical Association (NMA) and a former Chief Medical Director (CMD), Kogi Specialist Hospital (KSSH) Lokoja, urged parents and guardians to avail their children of the vaccination to justify government’s investment.

In his response, the Kogi NUJ Chairman, Mr Seidu Ademu, described the health sector as very critical, stressing that the vaccination was a right step in the right direction.

Ademu promised a robust partnership with WHO to enable the team to achieve its set goals.
He stressed the need to inform, educate and sensitise the general public on the need to embrace the vaccine by ensuring that girls within the age range were vaccinated.

Continue Reading

Health

NCDs will be leading cause of mortality in Africa by 2030 – WHO

Published

on

The World Health Organisation (WHO) says Non-communicable Diseases (NCDs) will become the leading cause of mortality in Africa by 2030 if urgent measures are not executed by member states.

Dr Matshidiso Moeti, WHO Regional Director for Africa, joining virtually, made the assertion on Tuesday at the opening of the first International Conference on PEN-Plus in Africa (ICPPA 2024) in Dar es Salaam, Tanzania.

The ICPPA 2024, holding from April 23 to April 25, is aimed at addressing severe NCDs in Africa.

It is being hosted by the WHO Regional Office for Africa, Helmsley Charitable Trust, and the United Republic of Tanzania. Moeti urged member states to embrace strategies that would help to address the issue.

“We are faced with non-communicable diseases and data from low and middle income countries show that 26 per cent of total health spending was due to NCDs, second only to infectious and parasitic diseases.

“Meaning it is urgent to give these often overlooked diseases priority attention as Africa is severely affected and more than in any other place in the world.

“The surge in the burden of NCDs on our continent over the past two decades, is driven by increasing incidences of risk factors, such as unhealthy diets, reduced physical activity, obesity, and air pollution.

“NCDs are set to overtake communicable, maternal, neonatal and nutritional diseases combined as a leading cause of mortality in Africa by 2030.

“And here, the NCDs are called silent epidemics. Unfortunately, this rapid devolution, with a higher mortality rate has not been recognised in the region, because we’re not investing adequately in detecting and lowering the burden of these diseases,” Moeti said.

Moeti noted that severe NCDs like type one diabetes, rheumatic heart disease, and sickle cell disease more frequently affect children and young adults in the majority of Africans population.

She advised that Africa must show increased commitment in addressing NCDs with adequate and sustained resources.

She also said there was the need to strengthen accountability and assess the impact of interventions by enhancing surveillance and monitoring.

According to Moeti, this can be achieved using reliable and timely data at national and sub national levels to drive policy and action as we move forward.

Ms Elke Wisch, UNICEF Representative to Republic of Tanzania, said that collaboration was at the heart of collective response to tackling NCDs.

“Today’s gathering underscores the urgency and importance of addressing NCDs comprehensively and collaboratively.

“The WHO package of essential non communicable  interventions for PEN, for primary healthcare and low resources settings, and the recently launched regional strategy on PEN-Plus provides a strategic framework  for tackling NCDs at their roots,” she said.

Also speaking, Ummy Mwalimu, Minister of Health, Tanzania, said that non communicable diseases NCDs, have become a formidable threat to the health and wellbeing of “our people.”

She urged for collective efforts to address these threats.

“They are silently affecting the lives of our citizens, our communities, undermining the progress we strive to achieve as a nation.

“The impact of these diseases extends beyond individual suffering.

“It affects our communities, our economy, and ultimately the future of our nations in our continent.

“Yet, in the face of these challenges, we are not discouraged together. We have chosen to confront these non-communicable diseases.’’

She urged for lifestyle change as positive way to combatting the negative outcomes of NCDs.

James Reid, Programme Officer for the Helmsley Charitable Trust’s Type 1 Diabetes (T1D) Programme, said he was happy at the level of interest and momentum in engagements to address NCDs, especially Type 2 diabetes.

He, however, identified finance as one of the biggest challenge and hindrance. He said that while political leaders and stakeholders identify the challenges that NCDs pose, the strategies to prevent them, especially NCD care, were limited.

“Leadership for driving of PEN-Plus is very important to make sure that ministry of health leaders and all others involved, really understand how to change the dynamics as well as adopt solutions to suit specific localities,” she said.

WHO’s PEN-Plus (Package of Essential NCD-Plus), is a regional integrated care delivery strategy to address severe non-communicable diseases at first-level referral health facilities.

At the 2022 WHO Regional Committee Meeting for the African Region, the 47 Member States of the AFRO region voted to adopt the PEN-Plus strategy.

It is focused on alleviating the burden among the poorest children and young adults. This is by increasing the accessibility and quality of chronic care services for severe NCDs including Type 1 diabetes, rheumatic heart disease, and sickle cell disease.

 ICPPA 2024 provides opportunity to shore up international support for scaling up PEN-Plus in the African Region. Also, the conference serves as a platform to raise awareness of severe NCDs, share lessons from countries implementing PEN-Plus and identify opportunities to strengthen NCD management.

Continue Reading

Trending